NEWTOWN, Pa., Sept. 17, 2014 /PRNewswire/ -- BioClinica®, Inc., a leading provider of outsourced clinical trial services and eClinical Solutions, today announced three of its experts are speaking at the 20th Annual SCDM Conference for Clinical Data Management to be held September 28 to October 1 in Las Vegas, Nevada. The Company also announced the innovative Compass technology, a risk-based monitoring solution to raise overall quality in clinical trials acquired earlier this year, is up for the Technology Innovation (TIA) Award. Among those presenting are Jonathan Andrus, Vice President, Strategic Accounts and eClinical Solutions and 2014 Chair of SCDM; Courtney McBean, Vice President, Clinical Innovation, eClinical; and Anna Levengood, Manager, Data Management Operations.
Details of 2014 SCDM Annual Conference Sessions in which BioClinica experts are presenting include:
Risk Based Monitoring: Drivers, Process, Tools, and Emerging Roles, Roundtable Session
Courtney McBean, Vice President, Clinical Innovation
September 29, 10:30 AM - Noon
A panel of experts including Compass co-developer Courtney McBean, will discuss the evolution of clinical data management in response to the rapidly shifting global regulatory and clinical trials landscape. They will examine tools, processes and roles to support targeted, reduced, and/or remote monitoring activities as part of Risk-Based Monitoring (RBM).
NextGen Technology Innovation Award Finalist Presentation, Plenary Session
Courtney McBean, Vice President, Clinical Innovation
September 30, 10:30 AM - Noon
Courtney will give a presentation on BioClinica's Compass technology selected as one of three finalists for the TIA, an award recognizing innovation that leverages novel technologies and processes used in clinical trials. The 2014 winner will be announced following finalist presentations.
Becoming a Certified Clinical Data Manager, Information Session
Anna Levengood, Data Management Operations
September 29, 5:00 PM - 6:00 PM
Anna will lead an informational session for professionals interested in clinical data management certification, including the CCDM certification process and exam preparation.
Other upcoming industry events where BioClinica is participating include:
- Outsourcing in Clinical Trials New England 2014
- 5th DIA Cardiac Safety Workshop in Japan
- Asia Clinical Trial Leader's Summit
- 7th Annual Clinical Trials on Alzheimer's Disease (CTAD) Conference
At each of these conferences, attendees will have an opportunity to converse with knowledgeable BioClinica representatives on latest trends in clinical trials and see live product demonstrations. To request a meeting with BioClinica during any of these events, call our hotline at 1-888-392-7456, email [email protected] or use our online Contact Us form.
About BioClinica, Inc.
BioClinica, Inc. is a leading global provider of integrated clinical trial management technologies including eClinical solutions for clinical trial supply management, forecasting and optimization (CTSM), electronic data capture (EDC), randomization (IRT), and clinical trial management (CTMS). BioClinica and SYNARC merged in 2014 to create the world's foremost medical imaging and cardiovascular core lab with unrivalled scientific, regulatory and project management capabilities for advancing clinical trials. Together, our company offers our clients the industry's most comprehensive and diversified clinical imaging program with therapeutically aligned experts and increased operational scale. With 30 years of experience and over 4000 successful trials to date, BioClinica has supported the development of many new medicines through all phases of the clinical trial process. BioClinica operates state-of-the-art, regulatory-body-compliant imaging core labs on three continents, and supports worldwide eClinical, comprehensive cardiovascular safety, and data management services from offices in the United States, Europe and Asia. For more information, please visit www.bioclinica.com.
Logo - http://photos.prnewswire.com/prnh/20130403/PH87647LOGO
SOURCE BioClinica, Inc.
Share this article